Long Survival (Cure) to Cisplatin/Infusional 5-Flurouracil in Metastatic Squamous Cell Anal Cancer with Extensive Liver and Lung Metastases - Case Reports in Clinical Medicine

CRCM > Vol.4 No.3, March 2015

Long Survival (Cure) to Cisplatin/Infusional 5-Flurouracil in Metastatic Squamous Cell Anal Cancer with Extensive Liver and Lung Metastases ()

HTML XML

Download as PDF (Size: 763KB) PP. 73-76

DOI: 10.4236/crcm.2015.43017 3,458 Downloads 4,660 Views Citations

Author(s)

Andrew Haydon^1,2*, Rebecca Tay¹, Gabriel Mak¹, Jeremy Shapiro^1,2

Affiliation(s)

¹Department of Medical Oncology, Alfred Hospital, Melbourne, Australia.
²Monash University, Melbourne, Australia.

ABSTRACT

Background: Metastatic anal Squamous Cell Carcinoma (SCC) is a relatively uncommon malignancy that is usually treated with palliative platinum based chemotherapy. Response rates are modest and complete responses are rare. Case Report: Here we report on a case of advanced SCC with the extensive visceral metastatic disease that has possibly been cured with chemotherapy alone. The patient has received 6 cycles of Cisplatin and 5FU and has remained in complete remission for over 7 years. Conclusion: This is the first report of a case of metastatic anal SCC that has been cured with chemotherapy and highlights the need to remain optimistic when treating patients with “palliative” chemotherapy.

KEYWORDS

Metastatic Anal Squamous Cell carcinoma, Chemotherapy, Cure

Share and Cite:

Haydon, A. , Tay, R. , Mak, G. and Shapiro, J. (2015) Long Survival (Cure) to Cisplatin/Infusional 5-Flurouracil in Metastatic Squamous Cell Anal Cancer with Extensive Liver and Lung Metastases. Case Reports in Clinical Medicine, 4, 73-76. doi: 10.4236/crcm.2015.43017.

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies